Recap: C4 Therapeutics Q2 Earnings

C4 Therapeutics CCCC reported its Q2 earnings results on Thursday, August 4, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

C4 Therapeutics beat estimated earnings by 18.84%, reporting an EPS of $-0.56 versus an estimate of $-0.69.

Revenue was up $4.05 million from the same period last year.

Last quarter the company missed on EPS by $0.07 which was followed by a 4.2% drop in the share price the next day.

Here's a look at C4 Therapeutics's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.58	-0.58	-0.59	-0.59
EPS Actual	-0.65	-0.31	-0.51	-0.51
Revenue Estimate	8.05M	7.08M	7.61M	6.02M
Revenue Actual	7.65M	20.09M	8.50M	9.78M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for C4 Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar